Insider Trading: Celgene Corp (CELG.O)

CELG.O on Nasdaq

119.02USD
2:02pm EDT
Change (% chg)

$0.80 (+0.68%)
Prev Close
$118.22
Open
$118.56
Day's High
$119.89
Day's Low
$118.52
Volume
2,849,050
Avg. Vol
4,603,948
52-wk High
$129.06
52-wk Low
$82.90

Search Stocks
BARKER RICHARD W
Trading Date Type Shares Traded Price Shares Held
12 Jun 2015 Buy 2,068 $0.00 8,857
12 Jun 2015 Sell 620 $111.32 8,857
11 Jun 2015 Buy 2,066 $0.00 8,857
11 Jun 2015 Sell 619 $111.32 8,857
24 Jul 2014 Sell 17,600 $87.03 5,962
24 Jul 2014 Buy 18,600 $31.80 5,962
12 Jun 2014 Sell 309 $159.99 2,481
12 Jun 2014 Buy 1,033 $0.00 2,481
11 Jun 2014 Buy 1,033 $0.00 2,481
11 Jun 2014 Sell 309 $160.22 2,481

Institutional Holders

% Shares Owned: 82.84%
# of Holders: 1,537
Total Shares Held: 657,063,170
3 Mo. Net Change: -8,313,225
# New Positions: 133
# Closed Positions: 73
# Increased Positions: 634
# Reduced Positions: 640
# Net Buyers: -6

Officers & Directors

Name Age Since Current Position

Robert Hugin

60 2014 Chairman of the Board, Chief Executive Officer

Mark Alles

56 2014 President, Chief Operating Officer

Thomas Daniel

61 2014 President, Research and Early Development

Peter Kellogg

59 2014 Chief Financial Officer, Executive Vice President

Jacqualyn Fouse

54 2014 President - Hematology & Oncology

Perry Karsen

60 2013 Chief Executive Officer of Celgene Cellular Therapeutics

Scott Smith

53 2014 President - Inflammation & Immunology

Michael Casey

69 2007 Lead Independent Director

Michael Bonney

56 2015 Director

Richard Barker

66 2012 Independent Director

Carrie Cox

57 2009 Independent Director

Michael Friedman

71 2011 Independent Director

Gilla Kaplan

68 1998 Independent Director

James Loughlin

72 2007 Independent Director

Ernest Mario

76 2007 Independent Director
Search Stocks